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        Neutrophils represent the most common leuko-
cytes in blood and are essential in innate im-
mune responses in response to pathogens (  1  ). 
However, the many defense mechanisms are 
also able to destroy normal tissues. Apoptosis is 
the most common physiological cell death of 
neutrophils both in vitro and in vivo, and it 
prevents the release of histotoxic contents from 
the dying cell and, therefore, limits tissue dam-
age. It has recently been demonstrated that 
cyclin-dependent kinase inhibitors enhance the 
resolution of established infl  ammation by pro-
moting neutrophil apoptosis (  2  ), suggesting 
that drugs targeting important molecules in the 
process of neutrophil apoptosis exhibit great 
pharmacological potential for the treatment of 
infl  ammatory disorders. 
  The induction of neutrophil apoptosis dur-
ing the resolution of an innate immune response 
can be mimicked in vitro by culturing the cells 
in the absence of suffi   cient amounts of survival 
factors, a process that is called spontaneous neu-
trophil apoptosis. Caspases are known to play a 
key role in this process, but it remains unclear 
when and how caspases are activated in neutro-
phils (  3  ). Caspases can be activated by death re-
ceptors of the TNF/nerve growth factor receptor 
family. Interestingly, the initiator or apical cas-
pase-8, which is activated by ligation of death 
receptors (  4  ), is also activated during spontane-
ous neutrophil apoptosis (  5  –  13  ). 
  However, a functional death ligand does not 
appear to play a role in this system. For instance, 
neutrophil apoptosis from Fas receptor  –   or Fas 
ligand  –  defi  cient mice is normal (  14, 15  ). More-
over, it is unlikely that, in the absence of in-
fl  ammation, neutrophil apoptosis is regulated via 
TNF receptors because there is no or only little 
TNF available. In addition,     60% of normal 
neutrophil populations do not express func-
tional TNF death receptors but still undergo 
spontaneous apoptosis with a normal kinetic (  16  ). 
Thus, there is little evidence for death recep-
tor  –  mediated initiation of neutrophil apoptosis 
in the absence of infl  ammation, and the mo-
lecular mechanisms leading to caspase-8 activa-
tion in these cells are not known. 
  Although the lysosomal cathepsins have of-
ten been considered as intracellular proteases 
able to mediate caspase-independent death (  17  ), 
there is also evidence that they act in concert with 
caspases in apoptotic cell death. In particular, 
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  In the resolution of infl  ammatory responses, neutrophils rapidly undergo apoptosis. We 
describe a new proapoptotic pathway in which cathepsin D directly activates caspase-8. 
Cathepsin D is released from azurophilic granules in neutrophils in a caspase-independent 
but reactive oxygen species  –  dependent manner. Under infl  ammatory conditions, the trans-
location of cathepsin D in the cytosol is blocked. Pharmacological or genetic inhibition of 
cathepsin D resulted in delayed caspase activation and reduced neutrophil apoptosis. 
Cathepsin D defi  ciency or lack of its translocation in the cytosol prolongs innate immune 
responses in experimental bacterial infection and in septic shock. Thus, we identifi  ed a new 
function of azurophilic granules that is in addition to their role in bacterial defense mecha-
nisms: to regulate the life span of neutrophils and, therefore, the duration of innate im-
mune responses through the release of cathepsin D. 686 CASPASE-8 ACTIVATION MEDIATED BY CATHEPSIN D | Conus et al.
mouse system (    40 vs. 88% mean cell death in 24-h cultures; 
  Fig. 1, A and B  ). To investigate the eff  ect of pharmacological 
inhibition of cathepsin B and D, we used the previously char-
acterized specifi  c cathepsin inhibitors CA-074-ME (CA), a 
cell-permeable inhibitor of cathepsin B and possibly other cys-
teine cathepsins (  29  ), and PepA, which, as mentioned in the 
Introduction, blocks the aspartic protease cathepsin D (  20  ). 
In initial experiments, we confi  rmed the specifi  city of these 
two inhibitors (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20072152/DC1). In contrast to CA, PepA 
delayed spontaneous death of human blood neutrophils in a 
concentration-dependent manner (  Fig. 1 B  ). The optimal 
concentration of PepA for death inhibition was 100     M. 
  We next investigated whether the antideath eff  ect medi-
ated by PepA was caused by inhibition of apoptosis. PepA 
reduced phosphatidylserine redistribution, a characteristic fea-
ture of apoptotic neutrophils (  12, 13  ), with the same effi   cacy 
as GM-CSF (  Fig. 1 C  , top). Agonistic anti-Fas antibody 
stimulation was used as an additional control and accelerated 
neutrophil apoptosis in this in vitro system, which was in 
agreement with previously published work (  12, 13  ). We also 
analyzed DNA fragmentation, another hallmark of apoptotic 
cells. Again, PepA and GM-CSF signifi  cantly blocked apop-
tosis, whereas anti-Fas stimulation resulted in increased DNA 
fragmentation (  Fig. 1 C  , bottom). Although human and mouse 
neutrophils appeared to undergo cell death with diff  erent ki-
netics, these data collectively suggested that cathepsin D ex-
erts proapoptotic activities in cultured mature neutrophils. 
  Cathepsin D translocation precedes cytochrome c release 
  To identify where cathepsin D is located within neutrophils, 
we performed double immunofl  uorescence analysis on ma-
ture neutrophils using confocal microscopy. Cathepsin D 
colocalized with myeloperoxidase (MPO) in freshly isolated 
neutrophils (Fig. S2 A, available at http://www.jem.org/cgi/
content/full/jem.20072152/DC1). MPO is known to be 
stored in azurophilic granules of neutrophils (  30  ). In contrast, 
cathepsin D did not colocalize with cytosolic caspase-3 (Fig. 
S2 B). These data suggested that cathepsin D is stored, like 
MPO, in azurophilic granules. Using an anti  –  cathepsin B an-
tibody, we observed the same results (unpublished data). Upon 
culturing for 3 h, a subpopulation of neutrophils showed a 
diff  use staining pattern for cathepsin D and MPO (  Fig. 2 A  , 
left; see Fig. S2 A for higher magnifi  cation; the same data 
were observed regarding cathepsin B [not depicted]), sug-
gesting the nonspecifi  c permeabilization of azurophilic gran-
ules and subsequent cytosolic release of at least some of its 
components.   Both GM-CSF and G-CSF preserved the punc-
tate pattern in the majority of the cells, whereas the pancas-
pase inhibitor z-VAD and PepA had no eff  ects. In agreement 
with these immunofl  uorescence data, GM-CSF and G-CSF, 
but not z-VAD, suppressed the enzymatic activity of cathep-
sin D in cultured neutrophils (unpublished data). 
  Mitochondria have been shown to be essential for opti-
mal apoptosis induction in neutrophils (  6, 8, 31  ). There-
fore, we analyzed the kinetics of mitochondrial release of 
the cysteine protease cathepsin B and the aspartic protease 
cathepsin D have been reported to be involved in apoptosis 
regulation (  18  –  20  ). Genetic evidence for the role of cysteine 
cathepsins in apoptosis is provided by studies showing resis-
tance against TNF-induced liver apoptosis in mice lacking 
cathepsin B (  19  ), perhaps because of insuffi   cient cleavage of 
Bid (  21  –  23  ). Cathepsin D was shown to activate Bax in T 
cells (  24  ) and to be involved in the release of cytochrome c 
from mitochondria in fi  broblasts (  20, 25  ). Moreover, pep-
statin A (PepA), a pharmacological inhibitor of cathepsin D, 
blocked mitochondrial cytochrome c release and caspase ac-
tivation in cardiomyocytes and fi  broblasts (  25, 26  ). Collec-
tively, these data suggested a role for lysosomes and cathepsins 
in proapoptotic pathways proximal to mitochondrial activa-
tion in at least some forms of apoptotic cell death. 
  Because neutrophils rapidly undergo apoptosis after phago-
cytosis of bacteria (  7, 27  ), we hypothesized that azurophilic 
granules, in which cathepsins are located and intracellular 
bacterial killing occurs, might be able to somehow trigger 
the normal apoptotic program in these cells. To resolve the 
issue of whether cathepsins are involved in neutrophil apop-
tosis pathways, we specifi  cally inactivated cathepsin B and D, 
respectively, by both genetic and pharmacological means. 
Our studies revealed that cathepsin D is released from azuro-
philic granules during the initial phase of neutrophil apoptosis, 
leading to death receptor  –  independent activation of caspase-8. 
Importantly, this newly identifi  ed alternative proapoptotic 
pathway of caspase-8 activation observed in neutrophils is 
blocked under infl  ammatory conditions and is crucial for the 
resolution of innate immune responses. 
    RESULTS   
  Cathepsin D, but not cathepsin B, defi  ciency delays 
neutrophil apoptosis 
  Neutrophils are known to express cathepsin G in azurophilic 
granules (  28  ). In initial experiments, we addressed the ques-
tion of whether the apoptosis-relevant cathepsins B and D are 
expressed in normal blood neutrophils and obtained evidence 
that this is the case as assessed by immunoblotting (unpub-
lished data). To determine the possible involvement of these 
cathepsins in the regulation of neutrophil apoptosis, we puri-
fi  ed neutrophils from normal as well as cathepsin B  –   and 
cathepsin D  –  defi  cient mice. Neutrophils were isolated from 
bone marrow and blood, and then cultured. Mature neutro-
phil populations from cathepsin D      /      mice demonstrated more 
viable cells compared with those isolated from wild-type or 
cathepsin B      /      mice (  Fig. 1 A  ).   In this model, we additionally 
observed that blood neutrophils die more rapidly than bone 
marrow neutrophils, perhaps because the mean age of these 
cell populations is lower compared with blood neutrophils. 
The delayed death of cathepsin D      /      cells was more pro-
nounced in blood compared with bone marrow neutrophils 
but was nevertheless also signifi  cant in the latter. 
  Similar to mouse neutrophils, human neutrophils also un-
derwent spontaneous cell death in vitro. Cell death, however, 
occurred somewhat slower in the human compared with the JEM VOL. 205, March 17, 2008 
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    Figure 1.         Lack of expression and pharmacological inhibition of cathepsin D, but not cathepsin B, delays neutrophil apoptosis.   (A) Viability 
assay. Mouse neutrophils from cathepsin D     /     ( n   = 7), cathepsin B     /     ( n   = 6), and wild-type (  n   = 6) mice were isolated from bone marrow (left) or blood 
(right) and cultured in the absence of cytokine support for 24 h before viability was measured. Values are means   ±   SD. *, P   <   0.05; **, P   <   0.01. (B) Viability 
assay. Concentration- and time-dependent effects of CA (left) and PepA (right) on human blood neutrophil death (  n   = 3). Values are means   ±   SD. *, P   <   
0.05; **, P   <   0.01. (C) PS redistribution (top) and DNA fragmentation (bottom) assays. Human blood neutrophils were analyzed after 8-h (PS analysis) and 
22-h (DNA analysis) cultures. (left) Values are means   ±   SD (  n   = 3). *, P   <   0.05. (right) The quantitative analysis (percentages) of early and late apoptotic 
cells is shown. Representative results from three independent experiments.     688 CASPASE-8 ACTIVATION MEDIATED BY CATHEPSIN D | Conus et al.
    Figure 2.         Cathepsin D is released into the cytosol and proceeds mitochondrial cytochrome c liberation during neutrophil apoptosis.   (A)  Con-
focal microscopy, cathepsin D colocalization, and staining pattern analysis. Freshly isolated and cultured neutrophils were stained with anti  –  cathepsin D 
and anti-MPO antibodies. (left) Representative data. Correlation coeffi  cient and statistical analysis are shown in Fig. S2 A. No detectable staining was 
observed using control antibodies (not depicted). Bar, 10     m. (right) Quantitative and statistical analysis of time-dependent cathepsin D release experi-
ments. Values are means   ±   SD (  n   = 3). The same data were observed if MPO and cathepsin B releases were investigated (not depicted). (B) Confocal JEM VOL. 205, March 17, 2008 
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microscopy, cytochrome c colocalization, and staining pattern analysis. Freshly isolated and cultured neutrophils were stained with anti  –  cytochrome c 
and anti-Smac antibodies. (left) Representative data. Correlation coeffi  cient and statistical analysis are shown in Fig. S2 C. No detectable staining was 
observed using control antibodies (not depicted). Bar, 10     m. (right) Quantitative and statistical analysis of time-dependent cytochrome c release experi-
ments. Values are means   ±   SD (  n   = 3). The same data were observed if Smac release was investigated (not depicted). (C) Histology and confocal micros-
copy using biopsies from patients. Tissue sections were stained with hematoxylin and eosin, anti  –  caspase-3 antibody/PI, and anti – cathepsin  D/anti-MPO 
antibodies. Cathepsin D localization was analyzed by staining pattern analysis. White arrows indicate apoptotic neutrophils. Boxed areas indicate higher 
magnifi  cations (far right). The results are representative of three independent experiments. Bars, 10    m.   
 
two   proapoptotic factors in cultured neutrophils in the pres-
ence and absence of PepA by immunofl  uorescence analysis 
(  Fig. 2 B  , left). As expected, cytochrome c and Smac demon-
strated a punctate staining pattern and appeared to colocalize 
in freshly isolated neutrophils (Fig. S2 C). The mitochondrial 
location of these two proapoptotic factors was confi  rmed by 
the demonstration of colocalization with the mitochondrial 
marker protein cytochrome oxidase subunit I (unpublished data). 
After culturing for 12 h, we obtained a diff  use staining pat-
tern in a signifi  cant proportion of neutrophils. In the presence 
of PepA and z-VAD, however, the numbers of cells turning 
into a diff  use pattern were signifi  cantly decreased. The same 
observation was made using GM-CSF and G-CSF. 
  We systematically counted the cells exhibiting a diff  use 
staining pattern and examined cathepsin D and cytochrome c 
releases in a time-dependent manner (  Fig. 2, A and B  , right). 
Our data clearly indicated that cathepsin D release occurs ear-
lier than cytochrome c release. Moreover, because PepA and 
z-VAD blocked cytochrome c release, it can be concluded 
that both cathepsin D and caspase activities are required for 
the proapoptotic activation of mitochondria in neutrophils. 
Collectively, these data suggested that caspase-independent 
permeabilization of azurophilic granules occurs in early phases 
of neutrophil apoptosis. This process preceded the caspase-
dependent liberation of mitochondrial proapoptotic factors and 
is blocked by survival cytokines. 
  To confi  rm that azurophilic granules undergo permeabil-
ity changes and that the release of cathepsin D precedes cyto-
chrome c release from mitochondria, we analyzed the kinetics of 
translocation of these two proteins using cytosolic extracts from 
cultured neutrophils and immunoblotting (Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20072152/DC1). 
Although cathepsin D was already detected in cytosols from 
3-h cultured neutrophils, we obtained evidence for cyto-
chrome c at later time points only (6 and 9 h). These data 
further supported the concept that membranes of azurophilic 
granules are permeabilized before those of mitochondria dur-
ing neutrophil apoptosis. Moreover, transmission electron 
microscopy of cultured neutrophils demonstrated damaged 
azurophilic granule membranes, suggesting the permeabilization 
of these organelles in this process (Fig. S4). 
  To demonstrate cathepsin D and B expression and their 
potential release in neutrophils under in vivo conditions, we 
analyzed neutrophils in tissue sections of patients suff  ering 
from infl  ammatory diseases. Leukocytoclastic vasculitis is a skin 
disorder known to be associated with apoptotic neutrophils 
present in skin lesions (  32  ). We confi  rmed multiple apoptotic 
neutrophils in the dermis of these patients, as determined by 
regular histology and activated caspase-3 staining. Immuno-
fl  uorescence analysis on these tissues demonstrated evidence 
for cathepsin D and MPO releases in these cells (diff  use staining 
pattern;   Fig. 2 C  ). In contrast, we detected almost no apop-
totic neutrophils in tissue sections from patients suff  ering from 
ulcerative colitis and acute appendicitis, in which neutrophils 
exhibited a punctate staining pattern, suggesting that azurophilic 
granules were intact. We also performed cathepsin B stainings 
and obtained the same results (unpublished data). In conclu-
sion, permeabilization of azurophilic granules and the subse-
quent release of cathepsins and MPO in apoptotic neutrophils 
is not only an in vitro phenomenon but also occurs in vivo. 
  Caspase activation triggered by cathepsin D 
  Because the proapoptotic activation of mitochondria was 
both cathepsin D and caspase dependent, but the release of 
cathepsin D (and its enzymatic activation) was caspase inde-
pendent, we addressed the question of whether active ca-
thepsin D is able to induce caspase activation. In agreement 
with previously published work (  8, 12, 16  ), we observed cas-
pase-8, caspase-3, and Bax cleavage in a time-dependent 
manner in association with spontaneous neutrophil apoptosis, 
as assessed by immunoblotting (  Fig. 3 A  ).   Caspase-8 cleavage 
proceeded caspase-3 cleavage both in spontaneous and Fas 
receptor  –  mediated apoptosis. Bax is cleaved by calpain-1 
during neutrophil apoptosis (  8  ), an event that is detectable 
before caspase-3 cleavage. PepA but not CA blocked cleav-
ages of caspase-8, caspase-3, and Bax, confi  rming that phar-
macological inhibition of cathepsin D but not cathepsin B 
delays neutrophil apoptosis. 
  Although we obtained evidence for the generation of ac-
tive caspases in these experiments (a 15-kD fragment of cas-
pase-8 and a 17-kD fragment of caspase-3), previous work 
suggested that cleavage does not necessarily indicate caspase 
activation (  33  ). Therefore, we also analyzed the eff  ect of 
pharmacological inhibition of cathepsin D on enzymatic cas-
pase activities in cultured neutrophils. Spontaneous neutro-
phil apoptosis was associated with increases of both caspase-8 
and -3 activities, which were completely blocked by PepA 
(  Fig. 3 B  ). PepA did not directly block the activity of pure 
caspase-8 or -3 enzymes (Fig. S1 B), suggesting that cathepsin 
D is indeed able to trigger caspase activation in neutrophils. 
  Cathepsin D directly activates caspase-8 
  Bid has been described as a target of cathepsin B in vitro 
(  21  –  23  ). Therefore, we hypothesized that cathepsin D is also 690 CASPASE-8 ACTIVATION MEDIATED BY CATHEPSIN D | Conus et al.
extracts of freshly isolated blood neutrophils (  Fig. 4 D  ). We also 
used cytosolic extracts of the small cell lung carcinoma (SCLC) 
lines U1285 (caspase-8 containing) and SW2 (caspase-8 defi  -
cient) and confi  rmed that cathepsin D  –  mediated caspase-3 
cleavage (17-kD fragment) is caspase-8 dependent (  Fig. 4 E  ). 
  Although cathepsin D activated caspase-8, it remained 
unclear whether this is a direct or an indirect process. To ad-
dress this question, we performed identical in vitro experi-
ments using pure recombinant human caspase-8 and -3 proteins 
instead of cytosolic extracts. Cathepsin D cleaved caspase-8 
(15-kD fragment) but not caspase-3 (  Fig. 5 A  ).   Moreover, 
the generated caspase-8 fragment was enzymatically active 
because it was trapped by bVAD-fmk. In contrast, no active 
enzyme was generated in the presence of PepA (  Fig. 5 B  ). 
Sequencing by Edman degradation revealed that cathepsin D 
cleaves caspase-8 at Leu 237, resulting in a C-terminal fragment 
of the p18 subunit. The relative molecular mass of this fragment, 
deduced from mass spectrometry, was 15.48 kD. Compari-
son of caspase-8 sequences of diff  erent species suggested that 
the cathepsin D cleavage site is highly conserved (  Fig. 5 C  ). 
  Cathepsin D defi  ciency prolongs innate immune responses 
  To determine whether the newly identifi  ed proapoptotic 
pathway resulting in caspase-8 activation in the absence of 
death receptor signaling is relevant in a more physiological 
able to cleave cellular substrates involved in apoptosis regula-
tion. In an in vitro cell-free assay using cytosolic extracts of 
freshly isolated blood neutrophils, we observed that the addi-
tion of cathepsin D, but not cathepsin B, was followed by 
the cleavage of caspase-8 (15-kD fragment) and caspase-3 
(17-kD fragment) in a concentration- and time-dependent 
manner (  Fig. 4, A and B  ).   As seen during spontaneous neutro-
phil apoptosis, caspase-8 cleavage was again detectable before 
caspase-3 cleavage in this cell-free system. In the presence 
of PepA, cathepsin D  –  induced caspase cleavages were com-
pletely prevented (  Fig. 4 A  ). In addition, the caspase-8 fragment 
generated by incubation of cytosolic extracts with cathepsin 
D could be affi   nity labeled with the biotinylated caspase sub-
strate VAD-fmk (bVAD-fmk;   Fig. 4 B  , right), suggesting that 
the 15-kD fragment of caspase-8 is enzymatically active (  34  ). 
Additional enzymatic measurements confi  rmed that cathep-
sin D, but not cathepsin B, increased the enzymatic activities 
of both caspase-8 and -3 in the cytosolic extracts of neutro-
phils (  Fig. 4 C  ). 
  Cathepsin D processed and activated both caspase-8 and -3 
in vitro, but the cleavage of caspase-8 seemed to be earlier than 
that of caspase-3. Therefore, we hypothesized that caspase-8 
is required for caspase-3 activation in neutrophils. Indeed, 
cathepsin D was unable to mediate caspase-3 cleavage (17-kD 
fragment) after immunodepletion of caspase-8 in cytosolic 
    Figure 3.         Pharmacological inhibition of cathepsin D, but not cathepsin B, blocks caspase and calpain activation.   (A) Immunoblotting. Neutrophils 
were cultured for the indicated times in the presence and absence of the indicated inhibitors and anti-Fas antibody. Bax cleavage in neutrophils is caused by 
calpain activation. The same results were obtained in two additional independent experiments. Arrowheads indicate key cleavage products. (B) Caspase activity 
assays. Human blood neutrophils were analyzed immediately after isolation (fresh) and upon a 9-h culture period. Values are means   ±   SD (  n   = 3). *, P   <   0.05.    JEM VOL. 205, March 17, 2008 
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    Figure 4.         Cathepsin D activates caspase-8, which is required for subsequent caspase-3 activation.   (A) Immunoblotting. Concentration-
dependent cleavage of caspase-8 and -3 proteins by cathepsin D, but not cathepsin B, in cytosolic extracts from freshly isolated human blood 
neutrophils. Results are representative of three independent experiments. (B) Time-dependent cleavage of caspase-8 and -3 proteins by cathep-
sin D, but not cathepsin B, in cytosolic extracts from freshly isolated human blood neutrophils. Cytosolic extracts were also used for affinity 
labeling with bVAD-fmk and analyzed by immunoblotting. Results are representative of three independent experiments. (C) Caspase activity as-
says in cytosolic extracts of freshly isolated human blood neutrophils after treatment with cathepsins. Values are means   ±   SD (  n   = 3). *, P   <   
0.05. (D) Immunoblotting. Cleavage of caspase-3 (17-kD fragment) mediated by cathepsin D in normal and caspase-8  –  immunodepleted cytosolic 
extracts from neutrophils. Results are representative of three independent experiments. (E) Immunoblotting. Cleavage of caspase-3 (17-kD frag-
ment) mediated by cathepsin D in caspase-8  –  expressing and   –  deficient cytosolic extracts from SCLC lines. Arrowheads in A, B, D, and E indicate 
key cleavage products.     692 CASPASE-8 ACTIVATION MEDIATED BY CATHEPSIN D | Conus et al.
setting, we injected wild-type and cathepsin D      /      mice in-
traperitoneally with low-dose LPS. In this experimental model 
of bacterial peritonitis, we observed a moderate increase in 
blood neutrophil numbers peaking at 24 h in wild-type mice 
(P   <   0.05). 32 h after LPS injection, neutrophil numbers 
started to decline. Compared with wild-type mice, cathepsin 
D      /      mice demonstrated much higher neutrophil numbers 
at 24 h that further increased 32 h after LPS administration 
(  Fig. 6 A  ).   We also analyzed the numbers of peritoneal lavage 
neutrophils 32 h after LPS injection. Although almost no 
neutrophils were detected in wild-type mice, cathepsin D      /      
mice demonstrated evidence for peritoneal neutrophilic infi  l-
tration (  Fig. 6 B  ). In addition, although practically all peritoneal 
lavage neutrophils underwent rapid apoptosis, the neutrophils 
from cathepsin D      /      mice were apoptosis resistant (  Fig. 6 C  ). 
  Macrophages have been shown to be key cellular players 
in the uptake of apoptotic neutrophils and in the resolution 
of infl  ammation (  35, 36  ). Therefore, the possibility existed 
that the increased infl  ammation seen in cathepsin D      /      mice 
    Figure 5.         Cathepsin D directly activates caspase-8.   (A)  Immuno-
blotting. (top) Concentration-dependent cleavage of pure recombinant 
caspase-8 by cathepsin D. (bottom) Cathepsin D did not cleave caspase-3. 
Results are representative of three independent experiments. (B) Immuno-
blotting. (top) Cleavage of pure recombinant caspase-8 in the presence 
and absence of 100     M PepA. (bottom) The in vitro  –  cleaved 15-kD frag-
ment of caspase-8 associated with bVAD-FMK. Results are representative 
of three independent experiments. (C) Sequence analysis. The 15-kD frag-
ment was sequenced by Edman degradation. Cathepsin D cleaved cas-
pase-8 within the p18 subunit at Leu 237. The sequence alignment was 
performed with ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.
html) using sequence data obtained from GenBank/EMBL/DDBJ under 
accession numbers   Q14790  ,   O89110  , and   Q81RY7  . Arrowheads in A and B 
indicate key cleavage products.     
    Figure 6.         Lack of cathepsin D amplifi  es and prolongs infl  ammation 
in experimental peritonitis.   (A) Blood neutrophil numbers after applica-
tion of low-dose LPS (30   μ  g) in wild-type (  n   = 6) and cathepsin D     /    
(  n   = 7) mice. Values are means   ±   SD. *, P   <   0.05; **, P   <   0.01. (B) Neutrophil 
numbers in peritoneal lavage fluid in wild-type (  n   = 6) and cathepsin 
D     /     ( n   = 7) mice 32 h after LPS application. Values are means   ±   SD. 
*, P   <   0.05. (C) PS redistribution assay. Peritoneal lavage fl  uid neutrophils were 
analyzed by fl  ow cytometry 32 h after LPS application and a subsequent 
24-h culture. The quantitative analysis (percentages) is shown in the sub-
panels. Results are representative of three independent experiments. 
(D) Phagocytosis assay. The percentages of neutrophils phagocytosed by 
macrophages are presented. Times indicate how long neutrophils were 
cultured before the assay. Values are means   ±   SD (  n   = 3 for wild-type and 
cathepsin D     /     mice).   JEM VOL. 205, March 17, 2008 
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percentage of phagocytosed neutrophils was seen between 
wild-type and cathepsin D      /      mice (  Fig. 6 D  ). We also ob-
served no diff  erence between wild-type and cathepsin D      /      
mice when we intraperitoneally injected low-dose LPS in the 
mice before performing the same macrophage phagocytosis 
assays (unpublished data). Collectively, these data excluded a 
defect in the uptake of apoptotic neutrophils and suggested 
that the stronger and prolonged infl  ammatory response in ca-
thepsin D      /      compared with wild-type mice is largely caused 
by a block of neutrophil apoptosis in this model of experi-
mental bacterial infection. 
  Because experimental LPS administration in mice repro-
duces a human bacterial infection only in part, we investi-
gated the newly identifi  ed cathepsin D  –  caspase-8 pathway in 
neutrophils of patients suff  ering from septic shock. Analysis 
of cathepsin D release in the cytosol in neutrophil cultures 
showed that at least 85% of the sepsis neutrophils maintained 
intact azurophilic granules with no evidence for perme-
abilization within the fi  rst 9 h. In contrast, at this time point, 
    90% of normal neutrophils released cathepsin D in the cy-
tosol (  Fig. 7 A  ).   Moreover, sepsis neutrophil cultures did not 
show evidence for caspase-8 cleavage within 9 h (  Fig. 7 B  ), 
further supporting the concept that caspase-8 activation is me-
diated by cathepsin D in neutrophils. Consequently, spontane-
ous neutrophil death (Fig. S5, available at http://www.jem
.org/cgi/content/full/jem.20072152/DC1) and apoptosis 
(  Fig. 7 C  ) was markedly delayed in sepsis under ex vivo con-
ditions. No diff  erence was observed regarding cathepsin D 
expression between normal and sepsis neutrophils as assessed 
by immunoblotting (unpublished data). 
  Reactive oxygen species (ROS) defi  ciency delays cathepsin D 
release and apoptosis 
  The absence or inhibition of cathepsin D delays but does 
not prevent neutrophil apoptosis. This suggests that alterna-
tive mechanisms must exist for apoptosis induction. Genetic 
defi  ciency of nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase or its pharmacological inhibition results in 
delayed neutrophil apoptosis (  12, 37  ). We therefore investi-
gated the eff  ect of combined inhibition of both ROS pro-
duction and cathepsin D activity on neutrophil apoptosis. 
Inhibition of ROS production was performed by diphenylenei-
odonium (DPI). Although pharmacological inhibition of both 
NADPH oxidase and cathepsin D demonstrated additive antid-
eath eff  ects, the complete prevention of neutrophil death was 
not achieved even under these conditions (  Fig. 8 A  ).   
  We next investigated whether ROS were required for 
the translocation of cathepsin D in the cytosol. To have a 
clean system, we used neutrophils from a patient with chronic 
granulomatous disease (CGD) that are unable to generate 
ROS based on a genetic defect in the NADPH oxidase. 
In the absence of ROS, we observed delayed cathepsin D   release 
(a culture period of 7 h was required to obtain cathepsin D 
release in 50% of the neutrophils, whereas only 1 h was re-
quired in normal neutrophil populations;   Figs. 2 A and 8 B  ). 
Interestingly, under ROS-defi  cient conditions, both GM-CSF 
was also the consequence of a clearance defect, resulting in 
the accumulation of neutrophils. We isolated both macro-
phages and neutrophils from wild-type and cathepsin D      /      
mice and analyzed the uptake of apoptotic neutrophils by 
macrophages in both systems in vitro. No diff  erence in the 
    Figure 7.         Block of cathepsin D release and subsequent apoptosis 
defect in blood neutrophils derived from patients with septic shock.  
(A) Confocal microscopy. Blood neutrophils from patients suffering from 
septic shock (  n   = 3) and control individuals (  n   = 3) were cultured for 3 
and 9 h, and analyzed as demonstrated in   Fig. 2 A  . Values are means   ±   SD. 
**, P   <   0.01; ***, P   <   0.001. The same data were observed if MPO and ca-
thepsin B releases were investigated (not depicted). (B) Immunoblotting. 
Time-dependent cleavages of caspase-8 and -3 in cultured blood neutro-
phils from patients suffering from septic shock and control individuals. 
Arrowheads indicate key cleavage products. Results are representative of 
three independent experiments. (C) PS redistribution assay. Blood neutro-
phils from control individuals and patients suffering from septic shock 
were cultured for 8 h, and analyzed by fl  ow cytometry. The quantitative 
analysis (percentages) is shown in the subpanels. Results are representa-
tive of three independent experiments.     694 CASPASE-8 ACTIVATION MEDIATED BY CATHEPSIN D | Conus et al.
is inhibited by the neutrophil survival cytokines GM-CSF and 
G-CSF in vitro and in vivo. Because phagocytosis of bacteria 
triggers apoptosis in neutrophils (  7, 27  ), it is also tempting to 
speculate that this previously reported death mechanism is initi-
ated by the release of lysosomal enzymes from the azurophilic 
granules in the cytosol. The exact molecular mechanisms regu-
lating the permeabilization of azurophilic granules under the 
diff  erent conditions remain to be investigated. 
  Apoptosis pathways in neutrophils including caspases have 
been intensively studied by several groups (  3, 5-13  ). How-
ever, the initial events leading to caspase activation have re-
mained obscure in these cells. Besides caspases, it has been 
recognized that noncaspase proteases play a role in apoptosis 
pathways in several cell types, including neutrophils (  8, 40  ). 
Although it has already been suggested that these proteases 
act in concert with caspases, our fi  nding that cathepsin D acts 
proximal to caspases and activates an initiator caspase was un-
expected. Moreover, the alternative pathway of caspase-8 ac-
tivation described in this paper resolves the issue of how this 
and G-CSF had only modest additional inhibitory eff  ects on 
cathepsin D release. The delayed cathepsin D release in 
ROS-defi  cient neutrophils was associated with no detectable 
cleavage of caspases (  Fig. 8 C  ) and reduced apoptosis (  Fig. 8 D  ). 
These data suggest that ROS are involved in the membrane 
permeabilization of azurophilic granules. 
    DISCUSSION   
  Lysosomal enzymes such as cathepsins and MPO are stored in 
the azurophilic granules of neutrophils and synthesized early 
during maturation of these cells in the bone marrow (  38  ). 
These enzymes are used during phagocytosis and intracellular 
killing (  30  ), as well as in the extracellular defense against bacte-
ria (  39  ). In this paper, we provide evidence for an important 
new function of azurophilic granules, namely, the induction 
of apoptosis in mature neutrophils. Azurophilic granules re-
lease cathepsin D, which directly activates the initiator cas-
pase-8, leading to subsequent calpain (as indicated by Bax 
cleavage) and caspase-3 activation. This proapoptotic  pathway 
    Figure 8.         Delayed cathepsin D release and subsequent apoptosis defect in ROS-defi  cient neutrophils.   (A) Viability assay. Neutrophils were iso-
lated from human control individuals and cultured in the presence and absence of 20     M DPI and 50     M PepA for 24 h before analysis. Values are means   ±   
SD from three independent experiments. *, P   <   0.05. (B) Confocal microscopy. Blood neutrophils from a patient suffering from CGD were cultured and 
analyzed as shown in   Fig. 2 A   and Fig. S2 A. (C) Immunoblotting. In contrast to normal neutrophils (  Figs. 3 A and 7 B  ), no active fragments were detect-
able in CGD neutrophils in up to 9-h culture periods. (D) PS redistribution assay. Blood neutrophils from a control individual and a CGD patient were cul-
tured for 8 h, and analyzed by fl  ow cytometry. The quantitative analysis (percentages) is shown in the subpanels.     JEM VOL. 205, March 17, 2008 
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defi  ciency amplifi  es and prolongs neutrophilic infl  ammation 
in vivo is notable. Future studies may provide new insights 
into how GM-CSF and G-CSF stabilize the membrane of 
azurophilic granules, which results in   “  functional cathepsin D 
defi  ciency,  ”   at least in terms of caspase-8 activation and sub-
sequent apoptosis induction. As indicated in this study, the 
stabilization of azurophilic granules might play an important 
pathogenic role in sepsis, CGD, ulcerative colitis, and appen-
dicitis. Besides ROS, another potential candidate regulating 
the permeability of azurophilic granules is Bax, which has 
been shown to regulate lysosomal membrane permeabilization 
(  49  ). In addition, heat shock protein 70 has been reported to 
promote cell survival by inhibiting lysosomal membrane perme-
abilization (  50  ). Independent from these pathogenic mecha-
nisms, permeabilization of azurophilic granules may provide 
a new therapeutic strategy to induce neutrophil apoptosis and, 
consequently, to resolve exaggerated innate immune responses. 
  MATERIALS AND METHODS 
  Reagents.     Both cathepsin B and D recombinant enzymes, the specifi  c col-
orimetric cathepsin B substrate (  N  -benzyloxycarbonyl (z)-Arg-Arg-para-
nitroaniline), and DPI were obtained from EMD. The specifi  c fl  uorogenic 
cathepsin D substrate ((7-Methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-
N-3-(2,4-Dinitro-phenyl)-L-2,3-diaminopropionyl-Ala-Arg-NH  2  ), human 
G-CSF, and mouse GM-CSF were obtained from R  &  D Systems. Human 
GM-CSF was obtained from Novartis. The caspase inhibitors z-Val-Ala-Asp 
(VAD)-fl   uoromethylketone (fmk) (z-VAD), z-Ile-Glu-Thr-Asp (IETD)-
fmk (z-IETD), and z-Asp-Glu-Val-Asp (DEVD)-fmk (z-DEVD) were ob-
tained from BD Biosciences. PepA, CA, sucrose, and LPS from   Escherichia 
coli   0111:B4 were purchased from Sigma-Aldrich. Anti-Fas agonistic mono-
clonal antibody (CH11) was obtained from MBL International. bVAD-fmk 
was obtained from MP Biomedicals. 
  Mice.     Cathepsin B      /     , cathepsin D      /     , and wild-type mice were generated 
in our laboratory as previously described (  51, 52  ). For all experiments, mice 
with a C57BL/6J background that were 3  –  4 wk old were used. Mice were 
maintained under pathogen-free conditions. All animal experiments were 
reviewed and approved by the Animal Experimentation Review Board of 
the State of Bern. 
  Cells.     Peripheral blood neutrophils were purifi  ed from healthy normal indi-
viduals and patients suff  ering from septic shock by Ficoll-Hypaque centrifu-
gation (  12, 13  ). Septic shock patients fulfi  lled the following inclusion criteria: 
(a) documented or suspected infection; (b) signs of systemic infl  ammation in 
response to infection; and (c) systolic arterial blood pressure   <  70 mm Hg, 
despite adequate fl  uid resuscitation, in the absence of other causes of hypo-
tension (  53  ). We also purifi  ed neutrophils from the blood of a patient with 
CGD. We obtained Institutional Review Board approval for the study from 
the Kantonale Ethikkommission Bern. The purity of the isolated human 
neutrophil populations was always   >  95%, as assessed by staining with Diff  -
Quik (Baxter) and light microscopy analysis. Neutrophils were also isolated 
from wild-type, cathepsin B      /     , and cathepsin D      /      mice. Mature mouse 
bone marrow (obtained from femur and tibia of the hind legs) and blood 
neutrophils (obtained by cardiac puncture) were positively selected using 
anti  –  Gr-1 monoclonal antibody (Miltenyi Biotec), as previously described (  54  ). 
The purity of the resulting mouse neutrophil populations was   >  90% (bone 
marrow) and   >  95% (blood), respectively. For macrophage phagocytosis 
assays, we injected 2  –  3 ml of ice-cold 30% sucrose solution in the peritoneal 
cavity of wild-type and cathepsin D      /      mice, gently palpated for     30  –  60 s, 
and aspirated the solution, which contained suffi   cient numbers of peritoneal 
macrophages. The SCLC cell lines U1285 (expressing caspase-8) and SW2 
(lacking caspase-8) (  55  ) were provided by Dr. U. Zangemeister-Wittke 
(University of Bern, Bern, Switzerland). 
caspase is activated in the absence of death receptor ligation 
in neutrophils. Because cathepsin D is ubiquitously present in 
lysosomes, it is possible that this pathway can also be used to 
activate apoptosis in other cells, such as SCLC cells. 
  To obtain original insights in the permeabilization pro-
cess of azurophilic granules, we performed experiments in 
neutrophils derived from a CGD patient. We obtained evi-
dence that ROS are involved, because CGD neutrophils dem-
onstrated delayed cathepsin D release compared with normal 
neutrophils. These data are in agreement with recent work 
published by Blomgran et al., who showed that during microbe-
induced apoptosis of human neutrophils, ROS-dependent 
lysosomal destabilization represent an early event (  41  ). This 
destabilization provoked the release of cathepsin B, which 
then induced the cleavage of the proapoptotic Bcl-2 protein 
Bid, mitochondrial damage, and subsequent caspase activa-
tion and apoptosis. Our data, however, suggest that cathepsin 
B is functionally unimportant for apoptosis induction, because 
its genetic and pharmacological inactivation had no infl  uence 
on neutrophil death. Clearly, additional work is required to 
better understand the molecular mechanisms leading to the 
membrane permeabilization of azurophilic granules during 
neutrophil apoptosis. 
  Cathepsin D is inactivated at the pH found in the cyto-
plasm (  42  ). How then can caspase-8 be activated by cathepsin 
D in a cell? One possibility is that caspase-8 is cleaved because 
of the known endopeptidase activity of cathepsin D (i.e., at 
least partially retained at a neutral pH) (  43, 44  ). On the other 
hand, because of the nonspecifi  c membrane permeabilization 
of azurophilic granules, it is likely that acidifi  cation of the cy-
tosol may occur, at least in close proximity to the granules, 
allowing cathepsin D to be completely active. Acidifi  cation 
of the cytosol has previously been noticed in apoptotic cells 
(  45, 46  ). Although, this study cannot completely explain how 
cathepsin D maintains its activity in the cytosol, the delayed 
neutrophil apoptosis in cathepsin D      /      mice represents the 
most direct demonstration that it is indeed the case. 
  How is caspase-8 activated by cathepsin D? At present, 
we do not understand the molecular mechanism of any initi-
ator caspase (  47  ). Two models have been proposed. Initially, 
it was thought that initiator caspases autoprocess themselves 
when they are brought into close proximity with each other. 
Later studies suggested that caspase-8 aggregation serves pri-
marily to facilitate dimerization of the enzyme and that this 
does not require interchain proteolysis. In contrast, interchain 
proteolysis, but not enforced dimerization of caspase-8 by 
Fas-associated protein with death domain, was a prerequisite 
for its activation by granzyme B or caspase-6 (  34, 48  ). There-
fore, the proteolytic processing of caspase-8 by cathepsin D 
might initiate its activation, but the exact mechanism remains 
to be investigated. 
  Most studies of neutrophil accumulation concentrate on 
adhesion and migration. In contrast, little information is avail-
able regarding the functional consequences of delayed neu-
trophil apoptosis in innate immune responses. Therefore, the 
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  Cathepsin B and D activities were measured using pure cathepsin B and 
D enzymes in the presence or absence of 100     M PepA and 10     M CA as 
enzymatic conversion of the colorimetric cathepsin B substrate or the fl  uo-
rogenic cathepsin D substrate after a 6-h incubation at 37  °  C, according to the 
manufacturer  ’  s instructions. 
  In vitro protease cleavage assays.     To investigate direct cleavage of cas-
pases by cathepsin D, 2   μ  l of pure caspase-8 (generated from histidine-tagged 
human caspase-8 cloned in PET15b [  57  ]; provided by K. Schulze-Osthoff  , 
University of D  ü  sseldorf, D  ü  sseldorf, Germany) and caspase-3 (provided by 
C. Borner, University of Freiburg, Freiburg, Germany) recombinant pro-
teins were incubated with 0.1 and 0.3 U cathepsin D in the presence or ab-
sence of 100     M PepA for the times indicated in the fi  gures at 37  °  C in 
buff  er D. Recombinant activated human caspase-8 was analyzed by mass 
spectrometry immediately after purifi  cation. Samples for Edman sequencing 
were prepared by blotting the separated cleavage products onto PVDF mem-
branes and cutting out the bands corresponding to the fragments of interest. 
Edman sequencing was performed at the Functional Genomics Center oper-
ated by the Swiss Federal Institute of Technology Zurich (ETH Z  ü  rich) and 
the University of Zurich, and mass spectrometry analyses were performed by the 
SVS MS-Plateform of the University of Geneva on a fee-for-service basis. 
  Histological examination.     Tissue sections from leukocytoclastic vasculitis, 
ulcerative colitis, and acute appendicitis patients were fi  xed in 4% paraformalde-
hyde and embedded in paraffi   n. 5-    m sections were stained with hematoxylin 
and eosin and examined by light microscopy (Axiovert 35; Carl Zeiss, Inc.). 
  Confocal laser scanning microscopy.     Cytospins with 2   ×   10  6   cells per 
milliliter were made from freshly purifi  ed neutrophils or neutrophils cul-
tured in the presence or absence of 100     M PepA, 50     M z-VAD, 25 ng/ml 
G-CSF, or 50 ng/ml GM-CSF on noncoated slides. Cells were fi  xed in 4% 
paraformaldehyde for 10 min at room temperature and washed three times 
in PBS (pH 7.4). Permeabilization of cells was performed with 0.05% sapo-
nin in buff  er A (3% BSA in PBS) for 5 min at room temperature and with 
acetone for 15 min at     20  °  C. To prevent nonspecifi  c binding, slides were 
incubated in blocking buff  er (33% human immunoglobulins, 33% normal 
goat serum, 33% BSA) for 1 h at room temperature. Indirect immunostain-
ings of cathepsin D, MPO, caspase-3, cytochrome c, CoxI, and Smac were 
performed by using the following primary antibodies diluted in blocking 
buff   er: monoclonal anti  –  cathepsin D (1:100; Sigma-Aldrich), polyclonal 
anti-MPO (1:6,000, Dako), polyclonal anti  –  caspase-3 (1:100; Cell Signaling 
Technology), monoclonal anti-CoxI (1:400; Invitrogen), monoclonal anti  –
  cytochrome c (1:100; BD Biosciences), and polyclonal anti-Smac (1:100; 
Imgenex). Mouse and rabbit control antibodies, respectively, were used at 
the same concentrations in each experiment. 
  Immunofl  uorescent stainings were also performed on 5-    m-thick para-
formaldehyde-fi  xed paraffi   n-embedded tissue sections from leukocytoclastic 
vasculitis, ulcerative colitis, and acute appendicitis patients. Slides were dried 
for 2 h at 52  °  C and deparaffi   nized. Slides were blocked and stained as de-
scribed in the previous paragraph. After incubation with primary antibodies, 
cells and tissues were incubated with the appropriate TRITC- and FITC-
conjugated secondary antibodies (1:500) for 1 h in the dark at room temper-
ature. For active caspase-3 staining, polyclonal anti  –  caspase-3 antibody 
(1:200; Cell Signaling Technology) was used. The antifading agent Mowiol 
(EMD) was added. Slides were covered by coverslips and analyzed by a con-
focal laser scanning microscope (LSM 510; Carl Zeiss, Inc.) equipped with 
Ar and HeNe lasers. To quantify the amount of cells with diff  use staining 
pattern (cathepsin D, MPO, cytochrome c, and Smac experiments), 100 cells 
were counted in randomly chosen regions, and the mean number of cells 
demonstrating diff  use staining was calculated. 
  For colocalization studies, unprocessed, unfi  ltered and undeconvoluted 
datasets were analyzed using Imaris software package (Bitplane AG), consid-
ering every singular layer of a stack separately. Quantitative data of colocalization 
events were determined by the statistics modules in the colocalization and 
Voxelshop software of the Imaris package. Intensities were given as the sum 
of all colocalizing voxels in a dataset, and a computer image was generated. 
  Cell cultures.     Human blood and mouse bone marrow neutrophils were 
cultured at 10  6   cells per milliliter. Mouse blood neutrophils were used at 
25   ×   10  4   cells per milliliter. Neutrophils were cultured in complete culture 
medium (RPMI 1640 containing 10% fetal calf serum) in the presence and 
absence of 50 ng/ml GM-CSF, 25 ng/ml G-CSF, 1   μ  g/ml anti-Fas, 0.5  –  20     M 
CA, 1  –  300     M PepA, 20     M DPI, and 50     M z-VAD for the times indi-
cated in the fi  gures. 
  Determination of cell death and apoptosis.     Neutrophil death was as-
sessed by uptake of 1     M ethidium bromide and fl  ow cytometric analysis 
(FACSCalibur; Becton Dickinson) (  12, 13, 56  ). To determine whether cell 
death was apoptosis, redistribution of phosphatidylserine (PS) in the presence 
of propidium iodide (PI) was measured by fl  ow cytometry (  12, 13, 56  ). 
Neutrophil apoptosis was also assessed by oligonucleosomal DNA fragmen-
tation (  12, 13, 56  ). 
  Gel electrophoresis and immunoblotting.     10  6   cells per milliliter were 
washed with PBS supplemented with protease inhibitor cocktail (Sigma-
Aldrich) and lysed with RIPA buff  er (50 mM Tris-HCl [pH 7.4], 150 mM 
NaCl, 0.25% sodium deoxycholate, 1% Nonidet P-40, 1 mM EGTA sup-
plemented with protease inhibitor cocktail). After a 10-min centrifugation to 
remove insoluble particles, equal amounts of the cell lysates, cell-free ex-
tracts, or subcellular fractionation extracts were loaded on gels (NuPage; In-
vitrogen). Separated proteins were electrotransferred onto polyvinylidene 
difl  uoride (PVDF) membranes (Immobilon-P; Millipore). The fi  lters were 
incubated overnight at 4  °  C in TBS/0.1% Tween 20/5% nonfat dry milk 
with mouse anti  –  caspase-8 (1:1,000; Cell Signaling Technology), rabbit 
anti-Bax (1:1,000; BD Biosciences), rabbit anti  –  caspase-3 (1:1,000; Cell Sig-
naling Technology); mouse anti  –  cathepsin D (1:1,000; Sigma-Aldrich), or 
mouse anti  –  cytochrome c (1:500; BD Biosciences) antibodies. For loading 
controls, stripped fi  lters were incubated with anti-GAPDH (1:3,000; Chem-
icon) monoclonal antibody. Filters were washed in TBS/0.1% Tween 20/5% 
nonfat dry milk for 30 min at room temperature and incubated with the ap-
propriate horseradish peroxidase  –  conjugated secondary antibody (GE Health-
care) in TBS/0.1% Tween 20/5% nonfat dry milk for 1 h. Filters were 
developed by an enhanced chemiluminescence technique (ECL kit; GE 
Healthcare) according to the manufacturer  ’  s instructions. 
  Cell-free assays.     20   ×   10  6   freshly isolated human blood neutrophils were 
washed with PBS containing 4% BSA and lysed for 35 min on ice in 60   μ  l 
of CEB buff  er (20 mM Hepes [pH 7.2], 250 mM sucrose, 10 mM KCl, 
1.5 mM MgCl  2  , 2 mM EDTA, 1 mM dithiothreitol (DTT), 100     M PMSF, 
10   μ  g/ml aprotinin). The lysis was completed with a mechanical homogeniza-
tion by 25 strokes. After a 1-h centrifugation step at 21,000   g   at 4  °  C, the 
supernatant (cytosol) was used for the cell-free assay. 10   μ  g of cytosolic frac-
tions was incubated for the times indicated in the fi  gures at 37  °  C in buff  er B 
(340 mM NaOAc, 60 mM acetic acid, 4 mM EDTA, 0.1% CHAPS, 8 mM 
DTT [pH 5.5]) or buff  er D (500 mM glycine-HCl [pH 3]) in the presence 
or absence of the indicated amounts of cathepsin B and D, as well as 100     M 
PepA. In some experiments, caspase-8 was removed from neutrophil cyto-
solic extracts by immunodepletion using 5   μ  g of anti  –  human caspase-8 anti-
body (Cell Signaling Technology). In other experiments, we prepared 
cytosolic extracts from SCLC cell lines U1285 and SW2, which were incu-
bated for 30 min at 37  °  C in the presence and absence of 0.3 U cathepsin D. 
All cell-free extracts were analyzed by immunoblotting. 
  Enzymatic caspase and cathepsin assays.     Caspase-3 and -8 activities were 
measured using pure caspase-3 and -8 enzymes in the presence or absence of 
100     M PepA, 10     M CA, 50     M z-IETD, and 50     M z-DEVD, or in total 
extracts prepared from mature neutrophils cultured in the presence or absence 
of 100     M PepA using commercial caspase-3 and -8 cellular activity assay 
kits (QuantiZyme; BIOMOL International, L.P.), according to the manu-
facturer  ’  s instructions. In addition, caspase-3 and -8 activities were measured in 
cytosolic extracts from mature granulocytes in the presence and absence of 
0.6 U cathepsin B, 0.3 U cathepsin D, and 100     M PepA for 30 min at 37  °  C. 
Activated caspase-8 was also detected by precipitation with bVAD-fmk (  34  ). JEM VOL. 205, March 17, 2008 
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  Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-
mediated hepatocyte apoptosis and liver injury: implications for thera-
peutic applications.       Am. J. Pathol.       159  :  2045    –    2054  .   
        20  .   Roberg  ,   K.  ,   K.     K  å  gedal  , and   K.       Ö  llinger  .   2002  .   Microinjection of ca-
thepsin D induces caspase-dependent apoptosis in fi  broblasts.       Am. J. 
Pathol.       161  :  89    –    96  .   
        21  .   Cirman  ,  T.  ,  K.    Oresic  ,  G.D.    Mazovec  ,  V.    Turk  ,  J.C.    Reed  ,  R.M.    Myers  , 
  G.S.     Salvesen  , and   B.     Turk  .   2004  .   Selective disruption of lysosomes in 
HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple 
papain-like lysosomal cathepsins.       J. Biol. Chem.       279  :  3578    –    3587  .    
        22  .   Stoka  ,   V.  ,   B.     Turk  ,   S.L.     Schendel  ,   T.H.     Kim  ,   T.     Cirman  ,   S.J.     Snipas  , 
  L.M.     Ellerby  ,   D.     Bredesen  ,   H.     Freeze  ,   M.     Abrahamson  ,   et al  .   2001  . 
For quantitative analysis of colocalization, the Pearson  ’  s correlation coeffi   -
cient was calculated, as previously described (  58, 59  ). 
  Experimental peritonitis.     Cathepsin D      /      and wild-type mice were in-
jected intraperitoneally with 30   μ  g LPS. Blood was collected at the time 
points indicated in the fi  gures, and neutrophil numbers were analyzed by 
diff  erential counts using T  ü  rk solution (distributed by Dr. Grogg Chemie AG). 
After 32 h, mice were killed by CO  2   inhalation and injected intraperitoneally 
with 2 ml PBS. The peritoneal lavage fl  uid was collected and we performed 
diff  erential counts according to standard morphological criteria on cytospin 
preparations stained with Giemsa-May-Gr  ü  nwald solution (Sigma-Aldrich). 
In addition, neutrophils were isolated, cultured for 24 h, and subsequently 
analyzed regarding PS redistribution. 
  Macrophage phagocytosis assay.     Uptake of apoptotic mouse neutrophils 
by mouse macrophages was investigated as described previously (  16, 35  ), with 
slight modifi  cations. In brief,     2   ×   10  5   peritoneal macrophages of wild-type 
and cathepsin D      /      mice were cultured in complete culture medium on a 
glass coverslip in 24-well tissue culture plates (VWR International AG) in 
the presence of 50 ng/ml of mouse GM-CSF. 10  6   mature mouse bone mar-
row neutrophils of wild-type mice were cultured for the indicated times and 
added to macrophages at 37  °  C for 30 min. After coincubation, cells were 
fi  xed with 1% acetone-formalin and stained for MPO activity with di-
methoxybenzidine in the presence of hydrogen peroxide. Cells were lightly 
counterstained with Harris  ’   hematoxylin. The proportion of neutrophils phago-
cytosed by macrophages was determined by two independent investigators by 
counting in at least fi  ve fi  elds (a minimum of 100 neutrophils was evaluated). 
  Statistical analysis.     Statistical analysis was performed using the Mann-
Whitney U test. The fi  gures show mean levels   ±   SD. For multiple compari-
sons, diff  erences of the mean levels were analyzed using analysis of variance, 
followed by Tukey  ’  s HSD test. P   <   0.05 was considered statistically signifi  -
cant. For colocalization studies, Pearson  ’  s correlation coeffi   cient was deter-
mined in at least 10 diff  erent cells, and means   ±   SD were calculated. 
  Online supplemental material.     Fig. S1 demonstrates the specifi  city of 
the pharmacological inhibitors PepA and CA. Fig. S2 demonstrates the lo-
calization of cathepsin D in azurophilic granules and its translocation in the 
cytosol. Results of quantitative colocalization analysis are provided. Fig. S3 
demonstrates the time-dependent appearance of cathepsin D in the cyto-
sol compared with cytochrome c, as assessed by immunoblotting. Fig. S4 
shows a transmission electron micrograph suggesting membrane perme-
abilization of azurophilic granules during neutrophil apoptosis. Fig. S5 il-
lustrates the delayed spontaneous death of blood neutrophils from septic 
shock patients compared with control individuals. Supplemental materials 
and methods describes subcellular fractionation and transmission electron 
microscopy. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20072152/DC1. 
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